Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FGXYA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,194
Award facts
- Contract value 100% obligated
- $20,193.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $20,193.88. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company maintains an extensive portfolio of pharmaceutical products and medical supplies spanning multiple therapeutic domains, from specialty medications and brand-name drugs to vaccines and medical devices. All of AmerisourceBergen's reviewed federal contract awards have been non-set-aside and competitively awarded, demonstrating the company's capability to meet federal procurement standards in the open marketplace. The DLA is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple awards across separate regions, positioning AmerisourceBergen and other contractors to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FGXYA?
SPE2DB25FGXYA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FGXYA worth?
The government has obligated $20,194 on SPE2DB25FGXYA.
Is contract SPE2DB25FGXYA an order under another contract?
Yes. SPE2DB25FGXYA is a delivery order under SPE2DB24D2213, an indefinite delivery contract.
Was contract SPE2DB25FGXYA competed?
The extent of competition for SPE2DB25FGXYA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award